THE VISION
Paradigm shift in anastomotic technique
We innovate, manufacture and deliver
a new generation of surgical instruments
for colorectal surgery
HISTORY
2006
The start 2006
CarpoNovum is founded by two colorectal surgeons
Anders Grönberg, MD, PhD, engineer, and Prof. Henrik Thorlacius, MD, PhD
Award 2006
CarpoNovum received
Öhrlings Price Water House Coopers and LUIS Innovation awards
2007
Award 2007
CarpoNovum received the award for the most successful company in the Connect Sweden network
Award 2007
CarpoNovum received the national Skapa Development Award
2011
CE 2011
CARP®, predecessor of C-REX®, received CE marking
Developing 2011-2018
C-REX® device family was developed, clinical studies were conducted in Sweden, Denmark and China.
2018
CE 2018
C-REX® device family received CE marking
2020
Scandinavian CCS 2020
A subsidiary of CarpoNovum AB, is formed for surgical education and clinical practice.
ABOUT
CarpoNovum is a Swedish company innovating, manufacturing and delivering a new generation of surgical instruments for colorectal surgery.
Company’s headquarters, in-house R&D and manufacturing facilities are in Halmstad, Sweden.
Scandinavian Centre for Colorectal Surgery, a subsidiary of CarpoNovum, performs all clinical activities, including surgeons' training and accreditation.
BOARD OF DIRECTORS
Thomas Enckell, Attorney-at-law
President of the Board
​
Thomas is an expert of corporate and property law with solid experience in sales and acquisitions of companies as well as in advisory roles for funds, institutions, private equity and venture capital players.
Anders Grönberg, MD, PhD
Member of the Board
​
Anders is a senior colorectal surgeon with over 20 years of surgical practice and the engineer behind C-REX®. In addition to his engagement at CarpoNovum, Anders is a CEO of the Scandinavian Centre for Colorectal Surgery.
Jonas Gulliksson, Attorney-at-law
Member of the Board
​
Jonas is a senior lawyer with over 40 years of experience in national and international patent and intellectual property litigation and arbitration.
MEDICAL ADVISORY BOARD
Torbjörn Holm, MD, PhD
Magnus Jansson
Gunnar Németh, MD, PhD
Ludvig Arbin
Björn Zackrisson, MD, PhD
Christophe Genetay
Q&R
Quality and Regulatory
C-REX® devices are CE-marked in Europe. Regulatory approval has been achieved by complying with Medical Device Directive 93/42/EC as Class IIa devices and CarpoNovum holds a certificate of current version of EN ISO 13485.
Quality policy
All team members of CarpoNovum are committed to improve lives of people undergoing colorectal surgery, by providing high-quality, safe and effective products and services that meet our customers’ needs, with focus on continual improvement, by:
-
having a close collaboration with leading surgeons and health care professionals
-
complying with all applicable regulatory requirements
-
continually improving the effectiveness of our Quality Management System
-
periodically reviewing the performance of the Quality Management System and our Quality Objectives
-
communicating this Quality Policy to all team members, subcontractors and suppliers to assure that it is understood and implemented
​
​